Bendectin and Birth Defects

Michael D. Green is Professor of Law at the University of Iowa.

"Important reading for obstetrician-gynecologists and family physicians who provide obstetrical services." (New England Journal of Medicine) "Should be required reading in all law schools, and should be part of continuing education activities for judges and attorneys." (Judicature)

• PrefaceAcknowledgmentsChapter 1-A Birth Defect Child Is BornChapter 2-Locating Bendectin within the Mass Toxic LandscapeChapter 3-The Science of Determining Toxic CausationChapter 4-The Food and Drug AdministrationChapter 5-The Wm. S. Merrell CompanyChapter 6-A Mother's QuestChapter 7-The Mekdeci CaseChapter 8-The Unraveling of MekdeciChapter 9-The Proliferation of Bendectin LitigationChapter 10-Litigating a Multidistrict CaseChapter 11-The Withdrawal of BendectinChapter 12-Forging a Mass Toxic Substances TrialChapter 13-The Settlement and Unsettlement of MDL-486Chapter 14-The MDL-486 TrialChapter 15-Aggregative Procedure in Mass Toxic Substances LitigationChapter 16-The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual TrialsChapter 17-The Legacy of Bendectin for Toxic Causation LawChapter 18-The Lessons and Non-Lessons of Bendectin LitigationSelected BibliographyIndex